News

Delek Logistics Partners Earnings: What Investors Should Know

Delek Logistics Partners Earnings: What Investors Should Know

Anticipating Delek Logistics Partners' Quarterly Earnings

Delek Logistics Partners (NYSE: DKL) is gearing up to announce its latest quarterly earnings report soon, and investors are keen to know what lies ahead. Analysts have predicted that the company will report an earnings per share (EPS) of $1.07, which has many investors on the edge of their seats.

Understanding Investor Expectations

As the announcement approaches, the anticipation among investors is palpable. They are not just looking at past performance but are also focused on how the company will perform relative to estimates and future guidance. This is especially important as expectations can significantly influence stock prices.

Reviewing Historical Earnings Performance

Looking back at the last reported quarter, Delek Logistics Partners missed its EPS estimate by $0.20. This misstep resulted in a slight decline of 0.01% in the share price the following day.

Price Movements and Shareholder Sentiment

As of the most recent trading day, shares of Delek Logistics Partners were priced at $45.13, reflecting an increase of 18.77% over the past year. This positive upward trend suggests that long-term shareholders may feel optimistic heading into this earnings release.

Expert Opinions on Company Outlook

Staying informed about market sentiments is crucial for any investor. Analysts currently assign a Neutral rating to Delek Logistics Partners, based on assessments from a single analyst. The average target price over the next year is noted at $45.0, indicating a modest potential downside of 0.29% from current levels.

Comparative Analysis with Industry Peers

It's also useful to compare Delek Logistics Partners with its peers such as DHT Holdings, Teekay Tankers, and Scorpio Tankers. This peer analysis sheds light on how these companies are rated and their expected performance in the industry.

  • DHT Holdings has been given a Buy rating, with an average one-year price target of $15.67, implying a possible 65.28% downside.
  • Teekay Tankers holds a Buy rating and an average target price of $65.33, reflecting a potential upside of 44.76%.
  • Scorpio Tankers is similarly rated as Buy, with a price target suggesting a 57.01% upside at $70.86.

Summary of Peer Performance Metrics

This analysis brings to light important metrics for each company within the industry. Delek Logistics Partners ranks well in terms of gross profit, while its revenue growth is lagging compared to industry peers.

Business Operations and Market Positioning

Delek Logistics Partners LP is engaged in the ownership and operation of logistics and marketing assets relevant to crude oil as well as intermediate and refined products. The company's operations encompass gathering and processing, wholesale marketing and terminalling, and storage and transportation, often generating substantial revenue from its wholesale marketing segment.

Current Financial Landscape

Market Capitalization Overview: The market capitalization of Delek Logistics Partners is notably below industry averages, which can be connected to various factors, including growth prospects and operational limits.

Challenges with Revenue Growth: Over the most recent quarter, Delek reported a revenue decline of approximately -6.91%. This underperformance relative to peers raises concerns about its top-line revenue generation abilities.

Net Margin Situation: The net margin of 18.09% demonstrates challenges in achieving high profitability, indicating a need for more diligent cost management practices.

Return on Equity and Performance: The company excels in Return on Equity, achieving a noteworthy 68.88%. This signifies competent financial management and effective capital utilization.

Debt-to-Equity Ratio: Caution is warranted regarding debt management, as the company faces a higher-than-average debt-to-equity ratio, which could elevate financial risks.

Frequently Asked Questions

What is the projected earnings per share for Delek Logistics Partners?

The current analyst estimate for the earnings per share is $1.07.

How has Delek Logistics Partners performed over the last quarter?

In the last quarter, the company missed its EPS estimate by $0.20.

What is the current stock price of Delek Logistics Partners?

The stock was trading at $45.13, reflecting a notable increase over the past 52 weeks.

How do analysts rate Delek Logistics Partners?

Currently, the consensus rating is Neutral based on one analyst's perspective.

What industry comparison can be drawn for Delek Logistics Partners?

Comparing to peers, Delek stands out in gross profit but struggles with revenue growth relative to other companies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Thesis Elements Expands Portfolio with Mappify Buy

Updated Category News Views 32

Mappify Acquisition: A Smooth Move for Higher Ed Picture a college student trying to juggle classes, work, and life like it's a circus act. That's not too far off from reality, and it's where Thesis America and its new acquisition, Mappify, come into play. By scooping up Mappify, Thesis aims to untangle this scheduling chaos for students across the board. From Data to...

Continue Reading
iHeartMedia Faces Investigation; Shares Plummet 60%

Updated Category News Views 5

A Sudden Pivot Leaves Shareholders Reeling Nothing like a company blindsiding its investors amid the bustling market chaos. Welcome to the iHeartMedia saga, where promises of profit have turned into a bitter pill for shareholders. On November 9, 2026, the radio giant pulled a fast one by drastically revising its full-year Adjusted EBITDA forecast down to $550...

Continue Reading
Supermetrics Debuts AI Campaign Manager for Marketers

Updated Category News Views 88

These days, digital marketing feels like trying to build a puzzle in a sandstorm. You've got all these pieces flying around, valuable insights buried somewhere in the mix, and you can't just toss 'em together however you like. Supermetrics steps into this whirlwind with their new tool, Campaign Manager, promising marketers a direct line from insight to action. Finally, a...

Continue Reading
Jumptuit's AI Patent Promises Health Alerts Innovation

Updated Category News Views 85

Jumptuit's Patent: A Game-Changer in Health Tech Alright, strap in—Jumptuit just nabbed a patent that might flip the script on how we think about environmental health risks. The U.S. Patent and Trademark Office finally gave Donald Leka and his brainchild, Jumptuit, the green light on something they're calling 'AI Systems and Methods for Environmental Exposure and Early...

Continue Reading
Biozen Slashes BP Measurement Time by 40%, No Sacrifice

Updated Category News Views 41

Biozen's Bold Leap in Blood Pressure Measurement You think blood pressure measurement, you think inconvenience—right? Not so fast. Biozen's got something up their sleeve that's shifting the game. At the latest American Heart Association's Scientific Sessions in Chicago, Biozen's bigwigs whipped out their new tech: the BP2000. This isn't just any update; it's a 40% cut...

Continue Reading
Broadridge's Dividend Move: A Steady Signal

Updated Category News Views 133

Broadridge Puts a Cherry on Top with Dividend Declaration Ah, dividends—the bread and butter for those of us who savor the small victories that come with holding onto our stocks. Broadridge Financial Solutions, Inc. (NYSE: BR) just dangled a juicy carrot in front of its shareholders with their freshly declared quarterly cash dividend of $1.09 per share. Now, I've been...

Continue Reading
Nevada Organic Phosphate Cancels Share Consolidation Plan

Updated Category News Views 42

Unexpected Turn for Nevada Organic Phosphate In an abrupt twist that surprised some investors, Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) (FSE: ZV8), the Canadian trailblazer in organic phosphate mining, called off its proposed share consolidation. Dropping the plan wasn't just a stroke of luck; it came after hearing the grumblings of shareholders concerned...

Continue Reading
2027 Bass Legends Honored: NAMM Awards Spotlight

Updated Category News Views 73

A Celebration of Low-End Legends When it comes to those deep, booming riffs that make your spine tingle, the bass guitar holds a special place in the world of music. And at the 2027 Bass Magazine Awards, this unsung hero of countless tracks is getting its due recognition. Folks, we're talking about a star-studded lineup of bass legends who’ve turned the world of music...

Continue Reading
Grandparents' Holiday Gift Picks: Expertly Tested Ideas

Updated Category News Views 43

Hunting for the Perfect Gift? Look No Further The holiday hustle and bustle inevitably sparks one of the annual dilemmas: What on earth should you buy those grandkids of yours? No need to get all twisted up this season. Enter ZestYears, the savvy go-to guide for grandparents who want to nail gift-giving without breaking a sweat or the bank. These folks, based out of...

Continue Reading
Pyxus Starts Exchange Offer for 8.50% Notes, 2027

Updated Category News Views 70

Pyxus Restructures Via Exchange Offer Pites, it's time for Pyxus International to show its hand. The global agricultural player has rolled up its sleeves, kicking off an exchange offer for its 8.50% notes maturing in 2027. With $148.3 million hanging in the balance, this move is their shot at managing debt and keeping things steady—like a farmer making sure the...

Continue Reading

Top 5 Most Recently Viewed Articles

Comarch Recognized as Leader in European e-Invoicing Market

Updated Category News Views 57

Comarch Achieves Recognition in European e-Invoicing Comarch has been named a Leader in the IDC MarketScape 2024 European Compliant e-Invoicing Vendor Assessment. This recognition highlights the company’s excellence in delivering exceptional e-invoicing solutions tailored for compliance across various European markets. Innovative Solutions by Comarch The IDC report...

Continue Reading
Imperial Metals Experiences Significant Growth in Q3 Results

Updated Category News Views 75

Imperial Metals Reports Strong Financial Performance for Q3 2024 Imperial Metals Corporation (TSX:III) has released its financial results for the third quarter of 2024, revealing impressive growth metrics that highlight the company's resilience and operational efficiency. Financial Highlights In the third quarter, Imperial Metals reported an adjusted EBITDA of $74.2...

Continue Reading
Cimplifi Gains Recognition for Excellence in AI Solutions

Updated Category News Views 212

Cimplifi Earns Relativity Solution Competencies Recently, Cimplifi, a front-runner in integrated eDiscovery services, made headlines with its remarkable achievement of securing two new solution competencies from Relativity. These include the Relativity aiR for Review competency and the Relativity aiR for Privilege competency. This recognition underlines Cimplifi's...

Continue Reading
Upcoming Subsea 7 S.A. Conference Call on Q3 2025 Results

Updated Category News Views 218

Subsea 7 S.A. Announcement for Third Quarter Results Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) is set to release its third quarter results for the year 2025. This significant financial report will cover the period that concluded on 30 September 2025, and the company plans to make it available on Thursday 20 November 2025 at 08:00 CET. Details of the Earnings Call...

Continue Reading
Japan's Approval of New Urothelial Cancer Treatment Brings Hope

Updated Category News Views 112

Japan's Major Medical Milestone for Cancer Treatment Astellas Pharma Inc. has recently made headlines with a significant milestone in cancer treatment: the approval of PADCEV™ (enfortumab vedotin) in combination with KEYTRUDA® (pembrolizumab) by Japan's Ministry of Health, Labour and Welfare (MHLW). This groundbreaking decision marks the first official approval of a...

Continue Reading